China drug formulation market could reach $150 billion by 2015

It has been well recognized that the drug formulation has been one of the valued-added technologies for both innovative drugs and generics as well as both small molecule drugs and biologics, noted a new report, titled Outlook of China Drug Formulation Market, added to the offering of Research and Markets.

Although the drug formulation industry has existed in China for decades, and growing numbers of Chinese drug companies are currently focusing on this area, their current technical skills and capability are still limited.

However, as the fast-growing Chinese pharmaceutical market is providing great opportunities to all types of dosage form drugs, the Chinese drug formulation industry is also currently experiencing significant changes. The growth and development of this Chinese industry have thus started receiving attention of the drug companies from around the world.